NCT02024724View on ClinicalTrials.gov

Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2017

Conditions
Typical Facial PainAtypical Facial Pain
Interventions
DRUG

Bupivacaine

4 mL of 0.25% bupivacaine

DRUG

Triamcinolone

40 mg of Triamcinolone

DRUG

Dexamethasone

4 mg of Dexamethasone

Trial Locations (1)

60611

Anesthesiology Pain Medcine Center, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT02024724 - Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain | Biotech Hunter | Biotech Hunter